Halozyme Therapeutics shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $32M | 494k | 64.63 |
| 2025-12-31 | $40M | 592k | 67.30 |
| 2025-09-30 | $29M | 388k | 73.34 |
| 2025-06-30 | $11M | 212k | 52.02 |
| 2025-03-31 | $17M | 266k | 63.81 |
| 2024-12-31 | $25M | 517k | 47.81 |
| 2024-09-30 | $113M | 2.0M | 57.24 |
| 2024-06-30 | $58M | 1.1M | 52.36 |
| 2024-03-31 | $34M | 829k | 40.68 |
| 2023-12-31 | $9.1M | 246k | 36.96 |
| 2023-09-30 | $912k | 24k | 38.21 |
| 2023-06-30 | $796k | 22k | 36.07 |
| 2023-03-31 | $10M | 272k | 38.19 |
| 2022-12-31 | $1.2M | 21k | 56.90 |
| 2022-09-30 | $817k | 21k | 39.53 |
| 2022-06-30 | $909k | 21k | 43.98 |
| 2022-03-31 | $940k | 24k | 39.88 |
| 2021-12-31 | $1.1M | 29k | 40.22 |
| 2021-09-30 | $1.2M | 29k | 40.68 |
| 2021-06-30 | $1.3M | 29k | 45.42 |
| 2021-03-31 | $978k | 24k | 41.67 |
| 2020-12-31 | $1.3M | 31k | 42.72 |
| 2020-09-30 | $1.1M | 41k | 26.27 |
| 2020-06-30 | $1.1M | 41k | 26.81 |